Akkaraju Srinivas disclosed buy in Kalaris Therapeutics Inc
Akkaraju Srinivas buy $1.2M of disclosed value in Kalaris Therapeutics Inc.
Signal
Insider Trade
Action
Buy
Capital
$1.2M disclosed value
Why it matters
Insider Form 4 disclosures can surface management and director trading activity. This card is generated from canonical action facts, not request-time scraping.